Cancer drug delays ‘costing lives’, says lobby group
02 February 2020 - 00:00
After two bouts of blood cancer and two bone-marrow transplants in seven years, Retha Wessels hoped her problems were over. But red tape and health-care economics have combined to land her with a R25,000 monthly bill for an anticancer drug, Revlimid.
This article is reserved for Sunday Times subscribers.
A subscription gives you full digital access to all Sunday Times content.
Please visit SundayTimes.co.za in your desktop to view our latest subscription options.
Already subscribed? Simply sign in below.
Sign InQuestions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.